NextCure and Avere to merge, targeting oral IL-23 therapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/24/2026

1. INTC
2. DECK
3. META
4. AMD
5. INFY
6. RNG
7. UNP
8. DGX
9. TMUS
10. SPY

Go back to NextCure and Avere to merge, targeting oral IL-23 therapy
(NASDAQ: AKRO) Delayed: 54.74 --0 (-0%)
Previous Close $54.74    52 Week High $ 
Open $54.74    52 Week Low $ 
Day High $54.74    P/E N/A 
Day Low $54.74    EPS $ 
Volume 1,238,509       

(NASDAQ: NXTC) Delayed: 4.10 -0.08 (1.91%)
Previous Close $4.18    52 Week High $ 
Open $4.20    52 Week Low $ 
Day High $4.53    P/E N/A 
Day Low $4.01    EPS $ 
Volume 141,987